dexcom.com - DXCM Company Value to Revenue Ratio

Public company logo of Dexcom (DXCM)

Microchip logistics risks are impacting asset values, as evidenced by the volatility in the EV/Sales business valuation. The current level is approximately 5946.03. A patent moat and sensor accuracy ensure leadership within the oligopoly, while steady demand from diabetics guarantees a stable cash flow, supporting the long-term financial health of DexCom, Inc. (DXCM).

DXCM DexCom, Inc.: EV/Sales Multiple in the range 11/23/2025 - 11/19/2026

DXCM (Dexcom Corp): analytical breakdowns and indicator data

Fundamental valuation:DexCom, Inc. DXCM
Mass-produced product of DexCom Inc

Investors are verifying the fundamental stability of DexCom, Inc. (DXCM) through multiples that exclude the impact of debt load on capitalization. By analyzing the company's price-to-sales trend, one can assess the real market value of the business per unit of sales without distortions from leverage. For DexCom, Inc. (DXCM), this metric reflects the efficiency of expanding production hubs in Asia and the US, confirming the ability to scale electronics deliveries while maintaining investment attractiveness.

Competitor analysis for DexCom, Inc.

PEN (Penumbra, Inc.) - Company Value to Revenue Ratio|NOVT: EV/Sales Multiple|HAE - Total Company Value-to-Revenue Ratio|INSP (Inspire Medical Systems Inc) - EV/Sales Multiple|PROCEPT BioRobotics Inc (PRCT) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple CNMD|Company Value to Revenue Pulse Biosciences, Inc. PLSE|EV/Sales Multiple INMD (inmodemd.com)|Picard Medical Inc. - Enterprise Value-to-Revenue Ratio|SRDX - Enterprise Value-to-Revenue Ratio|SENS: Enterprise Value-to-Revenue Ratio|NPCE (NeuroPace, Inc.) - Company Value to Revenue|Tactile Systems Technology, Inc. - Business Value to Revenue|SNWV (SANUWAVE Health Inc) - EV/Sales Multiple|EV/Sales Multiple Outset Medical|Enterprise Value-to-Revenue Ratio Electromed (ELMD)|LENSAR, Inc. (LNSR) - Enterprise Value-to-Sales Ratio|AVITA Medical Inc - Company Value to Revenue|EV/Sales Multiple Profound Medical Corporation PROF|Baird Medical Investment Holdings - EV/Sales Multiple|Total Company Value-to-Revenue Ratio EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume ICCM (IceCure Medical, Ltd.)|Enterprise Value-to-Revenue Ratio pulmonx.com|Company Value to Revenue TELA Bio, Inc. (TELA)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)